Lilly to Raise Mounjaro Prices in the UK from September
2025-08-15 / Read about 0 minute
Author:小编   

In response to pressure from former US President Trump on pharmaceutical companies, Lilly has announced an increase in the pricing of its diabetes medication Mounjaro in the UK, effective September. The company has assured that it has reached an agreement with the UK government to ensure that this price adjustment will not impact the procurement costs for the National Health Service (NHS), thereby maintaining patient access to the drug. Specifically, the monthly price of the highest dose of Mounjaro will rise from £122 to £330, marking a 170% increase, while prices for lower doses will increase by a range of 45% to 138%.